Biogen
BIIB
$127.62
Share price
0.84%
Change (1 day)
-43.64%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) Fails to deliver data
Key failure to deliver metrics for Biogen:
- Last SEC data release: 2025-05-30
- Last 15 days FTD volume: $0.1 M
- Last 3 months FTD volume: $7.8 M
- Last year FTD volume: $7.8 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Biogen (BIIB) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013
Volume in USD (price x number of shares), data since 2013Biogen (BIIB) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $28.93 M | -59.75% |
| 2024 | $71.88 M | 27.44% |
| 2023 | $56.4 M | -14.65% |
| 2022 | $66.08 M | 7.92% |
| 2021 | $61.24 M | -56.04% |
| 2020 | $0.13 B | 67.82% |
| 2019 | $83.01 M | -43.79% |
| 2018 | $0.14 B | 69.32% |
| 2017 | $87.22 M | -29.4% |
| 2016 | $0.12 B | -16.47% |
| 2015 | $0.14 B | -18.15% |
| 2014 | $0.18 B | 579.65% |
| 2013 | $26.59 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | $82.72 M | $0.33 B | 🇺🇸 USA |
 Gilead Sciences GILD | $0.16 B | $0.25 B | 🇺🇸 USA |
 AbbVie ABBV | $33.49 M | $0.23 B | 🇺🇸 USA |
 Pfizer PFE | $28.79 M | $0.35 B | 🇺🇸 USA |
 Johnson & Johnson JNJ | $8.74 M | $0.19 B | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.01 M | 🇺🇸 USA |
 Sanofi SNY | $28.15 M | $43.66 M | 🇫🇷 France |
 Bio-Rad Laboratories BIO | $3.09 M | $17.23 M | 🇺🇸 USA |
 Illumina ILMN | $3.85 M | $72.94 M | 🇺🇸 USA |
 Qiagen QGEN | $2.71 M | $4.94 M | 🇳🇱 Netherlands |